Pharmesis International Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Xuedan Wu
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.9yrs |
| CEO ownership | n/a |
| Management average tenure | 3.7yrs |
| Board average tenure | 10yrs |
Recent management updates
Recent updates
CEO
Xuedan Wu (61 yo)
6.9yrs
Tenure
CN¥980,394
Compensation
Mr. Xuedan Wu has been an Executive Director of Pharmesis International Ltd. since April 16, 2004 and has been its Chief Executive Officer since December 31, 2017. Mr. Wu served as the Chief Executive Offi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 6.9yrs | CN¥980.39k | no data | |
| Financial Controller | 8.4yrs | no data | no data | |
| Joint Company Secretary | less than a year | no data | no data | |
| Joint Company Secretary | less than a year | no data | no data |
3.7yrs
Average Tenure
Experienced Management: BFK's management team is considered experienced (3.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 20.6yrs | CN¥980.39k | no data | |
| Non-Independent Non-Executive Chairman | 19yrs | no data | no data | |
| Lead Independent Director | 1.1yrs | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data |
10.0yrs
Average Tenure
61yo
Average Age
Experienced Board: BFK's board of directors are seasoned and experienced ( 10 years average tenure).